ࡱ> jmi bjbj *D}c}cU %%%9998q,9U99"[[[666\U^U^U^U^U^U^U$WqZU%66666U%%[[U###6%[%[\U#6\U##bMQ><|QVHUU0U8R![L![>T>Tn![%T66#66666UU$!666U6666![666666666 : SAINT LOUIS UNIVERSITY Institutional Review Board Waiver of Consent, Principal Investigator (PI):IRB #:First Name / Last Name CredentialsTitle of Project: The research involves no more than minimal risk to the subjects.  The waiver will not adversely affect the rights and welfare of the subjects.  The research could not practicably be conducted without the requested waiver.  Whenever appropriate, the subjects or legally authorized representatives will be provided with additional pertinent information after participation.  If the research involves using identifiable private information or identifiable biospecimens, the research could not practicably be conducted without using such information or biospecimens in an identifiable format.  Indicate whether or not this study is a research or demonstration project to be conducted by or subject to the approval of state or local government officials. If yes, indicate what the research is designed to study, evaluate, or otherwise examine [a) Public benefit or service programs; b) Procedures for obtaining benefits or services under those programs; c) Possible changes in or alternatives to those programs or procedures; or d) Possible changes in methods or levels of payment for benefits or services under those programs.  The information listed in the waiver application is accurate and all research staff will comply with the consent regulations and the waiver criteria. I assure that the information I obtain as part of this research (including protected health information) will not be reused or disclosed to any other person or entity other than those listed on this form, except as required by law. If at any time I want to reuse this information for other purposes or disclose the information to other individuals or entity I will seek approval by the IRB. Signature of Principal Investigator (PI)Date First Name / Last Name CredentialsPrinted Name of Principal Investigator (PI) FOR IRB USE ONLY APPROVED ____________________________________________ IRB Authorized Representative Date   Federal Regulations: 45 CFR 46.116(d)(1-4); An IRB may waive the requirements to obtain informed consent provided that the IRB finds and documents that all four criteria listed above are justified.  Please note: If this research is associated with a product (biologic or device) regulated by the FDA, regulations 21 CFR Parts 50 and 56 do not allow for waiver of informed consent unless a circumstance described at 21 CFR 50.23 (Exception from General Requirements) or 21 CFR 50.24 (Exception for Emergency Research) applies. FDA regulations do allow for waiver of written consent if the research meets the required criteria outlined in Section B.  Note: Research staff is defined as ALL study personnel (including PI) that is involved in the research.     PAGE  PAGE 1 Revised: 01/2019 23:DEFGHJefghklopqͻ́o`oPo=oP%h jhq56CJOJQJ\^Jh jhqCJOJQJ\^Jh>*5CJOJQJ\^J"h jhq5CJOJQJ\^Jh jhqOJQJ^J&hh5CJ H*OJQJ^JaJ 0jh jhj!0J5CJ OJQJU^JaJ #h jhj!5CJ OJQJ^JaJ #h jhq5CJ OJQJ^JaJ h jhqCJOJQJ^J"h jhq5;CJOJQJ^J23HIJghop  $If $5$7$8$H$Ifgdq$a$gdq pqr+ $5$7$8$H$Ifkd$$IfTU\ g\ 'F F^  t0'44 BBapytTqrA C D E 쵣쒵ugYgYugYKYu@uKh$ OJQJ\^Jh jhOJQJ\^Jh jhqOJQJ\^Jh jhBPHOJQJ\^Jh jhOJQJ\^Jh jh8_AKH OJQJ^J h jhqCJOJQJ^JaJ"h jhq5CJOJQJ\^Jh jhqOJQJ^J) *h jhq6CJOJQJ\^JaJ)h jhq6CJH*OJQJ\^JaJ&h jhq5CJOJQJ\^JaJ5, $Ifgd}kd"$$IfTF g' FS  t0'    44 BapytT $5$7$8$H$IfjeZL= !^gdBPH & F+ !gdBPH  !gdBPHgdqkd0$$IfT0 'F   t 0'44 Bap ytTB C D i^P & F+ !gdBPH  !gdqwkd$$Ifl`'#  t 0644 lap yt(u !$Ifgd3 !$Ifgd(uD E F |ncTE !$Ifgd3 !$Ifgd(u  !gd & F+ !gdBPH  !gdqwkd$$Ifl`'#  t 0644 lap yt(u / 0 1 |n_P !$Ifgd3 !$Ifgd(u & F+ !gdBPH  !gdwkd6$$Ifl`'#  t 0644 lap yt(u . 2 3   $ % & ) * ~  MOؿؿؿxk^kQh jhqOJQJ^Jh jhOJQJ^Jh jhBPHOJQJ^J%jh jhj!0JOJQJU^Jh jh8_AOJQJ^Jh jh$ OJQJ\^JhOJQJ\^Jh jhcoGOJQJ\^JhcoGOJQJ\^Jh jhOJQJ\^Jh$ OJQJ\^Jh jhBPHOJQJ\^Jh jhOJQJ\^J1 2 3  xj_PP !$Ifgd(  !gd$  & F+ !gd$  !^gd$ wkd$$Ifl`'#  t 0644 lap yt(u   % & ' ( xj[LL !$Ifgd(  !^gdcoG & F+ !gd$  !^gd$ wkdh$$Ifl`'#  t 0644 lap yt( ( ) * + MNOPQRxssssssmaa $5$7$8$H$If$Ifgdq !^gd$ wkd$$Ifl`'#  t 0644 lap yt( RST}~F71$If$5$7$8$H$Ifgdqkd$$If4FZq`'N  t0'6    44 awpyt $5$7$8$H$IfOSTa|2R\ଚveTeTe h jhCJOJQJ^JaJ h jh8_ACJOJQJ^JaJ#h jh8_A5CJOJQJ^JaJ#h jh5CJOJQJ^JaJ#h jh8_ACJOJQJ\^JaJh jh8_AOJQJ^J)h jhq6CJH*OJQJ\^JaJ"h jhq5CJOJQJ\^Jh jhqOJQJ^J#h jhq5CJOJQJ^JaJ~5) $5$7$8$H$Ifkd$$If4FZq`'FBF  t0'6    44 Bawpyt$$5$7$8$H$Ifa$s $5$7$8$H$If$Ifzkd$$IfZ`''  t 0'644 awp yt $5$7$8$H$Ifjkd[ $$IfZq t0'644 awytt $5$7$8$H$Ifkd $$IfZqF  t 0'644 Bawp yt}}}}}q $$Ifa$gdgdq}kd $$IfZqF  t 0'644 Bawp yt SygXXXO $Ifgdq T$Ifgdq$ T$Ifa$gd T$Ifgdqvkd} $$IfTlGO  064 lap yt(uTYgdqgkd" $$IfTlGO064 laytTYZϽtgh jh8_AOJQJ^Jhh8_AOJQJ^JhCJOJQJ^JhCJOJQJ^JhhQCJOJQJ^Jh>*0JmHnHuh8_A h8_A0Jjh8_A0JUjh{fUh{fhj! hj!hj!CJOJQJ^JaJ-jhj!hj!0JCJOJQJU^JaJ#gdq  P h]hh]h&`#$(/ =!"#$%  $$If!vh#v #v#v#v^:V U  t0',5 555^/ 4 BBapytT $$If!vh#v #v#vS:V   t0',5 55S/ 4 BapytT$$If!vh#v #v:V   t 0',5 5/ 4 Bap ytT$$If!vh#v#:V l  t 065#ap yt(u$$If!vh#v#:V l  t 065#ap yt(u$$If!vh#v#:V l  t 065#ap yt(u$$If!vh#v#:V l  t 065#ap yt(u$$If!vh#v#:V l  t 065#ap yt( $$If!vh#v#:V l  t 065#ap yt( $$Ifw!vh#v#vN#v:V 4  t0'6+,55N5/ 4 awpyt$$Ifw!vh#v#vN#v:V 4  t0'6+,555/ 4 Bawpyt$$Ifw!vh#v':V   t 0'6,5'/ 4 awp yt$$Ifw!vh#v:V  t0'6,5/ 4 awyt$$Ifw!vh#v:V   t 0'6,5/ 4 Bawp yt$$Ifw!vh#v:V   t 0'6,5/ 4 Bawp yt$$If!vh#v:V l  0654ap yt(uT$$If!vh#v:V l0654aytT !v666666666vvvvvvvvv6666686666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@666_HmH nH sH tH 8`8 Normal_HmH sH tH @@  Heading 1$$@&a$5\JJ  Heading 2$ T@& 5CJ\>>  Heading 3$$@&a$58@8  Heading 4$@&5BB  Heading 5$$@&a$5CJ>>  Heading 6$@& >*CJ]BB  Heading 7$$@&a$5CJDA`D Default Paragraph FontVi@V  Table Normal :V 44 la (k (No List 4@4 Header  !4 @4 Footer  !.)@. Page NumberHC"H Body Text Indent CJOJQJ0"0 Caption5\>BB> Body Text5CJOJQJ\RR\ Body Text Indent 2p0^p`0 CJOJQJXSbX Body Text Indent 30^`0OJQJ>Pr> Body Text 2  5JQJ Body Text 3 7$8$H$ B*CJph4>4 Title$a$5CJJJ Subhead dx:@CJ OJQJ]6@6  Footnote Text@&`@ Footnote ReferenceH*HH 0 Balloon TextCJOJQJ^JaJN/N 0Balloon Text CharCJOJQJ^JaJ./. q Footer Charjj q Table Grid7:V 0 PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VGRU1a$N% ʣꂣKЛjVkUDRKQj/dR*SxMPsʧJ5$4vq^WCʽ D{>̳`3REB=꽻Ut Qy@֐\.X7<:+& 0h @>nƭBVq1u`X=:tڣf{Xx {dV=|kPo۵(h[x )IеnW[@;0PDbRy( "IROnVxCD' bJZ65I[adH+^D )>s=h ۟~7zWo^=[Qr||[?|̦ o{O=4?}}L$Xx%@|Ư'11%i$P,c[GD7sH5. 4kIƉZKTPBM HN7|nB#L7^`!\29pCH3nMb#$.'19b%+vJ~.!DI;DPz l 2I ͚;|y3+~Dؕjw0e1vdǪzO^I57y+d8bnv 4?6CK\M#= ċ(0'1 zxpWc/_X4/A_[)^&(fp[_NiK7@wd5= I?>q샏ꚝΡ5Ӵ>3m=͡|7;:۱&?8ټ<}9H}]Ru Vx~p{3AsP~\v!cZ 6JOw׃SB HfЖ gpj*4nR2BM} rfw[BfV= vͅh7/sɳ ̲B3뤓eH=J_:hn$O\ʧFn;/x.M#+d,W87+IwOťwF) uepwPϬ pV$2v Sv(C8L\~+l`k& Y iTU#p~XHYHeʹ,fͰ-;Y7XmM 9ͬYMm*/稺W(r2bUGڱ]]HYUcF8U~ۍZZnJmi}kn^l DF~  D TTTWq O  pD 1  ( R~ !  W!!8@0(  B S  ?ef '  333:GefggooACCFF./02)**~OOERp :GefggooACCFF./02)**~OOERp (Iy+&*#=8崡dzʱ6(}3QٜqM+<j!YS[lB0 j{f@ @UnknownG.[x Times New Roman5Symbol3. .Cx Arial3.[x Times5. .[`)Tahoma?= .Cx Courier New;WingdingsA$BCambria Math"hRqGRqGj2GJGJ!24 3qHP?8_A2!xxW8 +Waiver or Alteration of HIPAA AuthorizationSLU IRBMaureen Bresnahan(                           ! " # $ % & ' Oh+'0 , L X d p|,Waiver or Alteration of HIPAA Authorization鶹Ƶ IRBNormalMaureen Bresnahan2Microsoft Office Word@@#M@90@90GJ ՜.+,D՜.+,l( hp  鶹Ƶ ,Waiver or Alteration of HIPAA Authorization Title@@4_AdHocReviewCycleID_EmailSubject _AuthorEmail_AuthorEmailDisplayName_ReviewingToolsShownOnce)new documents for websitefrancisa@slu.eduAmber Francis  !"$%&'()*,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXZ[\]^_`bcdefghkloRoot Entry F 9<n@Data #1Table+[WordDocument *DSummaryInformation(YDocumentSummaryInformation8aMsoDataStore ^<P<LLDE4QO5YXQ==2 ^<P<Item  PropertiesUCompObj r   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q